Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches.

Maya Distribution, LLC recalled Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches. in a Class I action — the FDA's most serious tier, reserved for products with a reasonable probability of causing serious health consequences or death on Mar 20, 2018.

The recall was triggered by possible Salmonella contamination: "Samples collected by public health officials found the presence of Salmonella." Salmonella is one of the most common causes of U.S. foodborne illness, with symptoms that typically appear within six hours to six days of exposure.

The product reached multiple states, recorded by the FDA as "Recalled product was distributed to retail stores in AZ, IA, ID, IL, KS, MI, UT, and WY." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Salt Lake City, UT. The recall covers Unknown of product. The FDA has Terminated this recall (first reported May 16, 2018), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.